Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
DRUG ADDICTION TREATMENT AND RECOVERY ACT
Whereas, Oregonians need adequate access to drug addiction treatment. Oregon
ranks nearly last out of the 50 states in access...
One of the psychoactive mushrooms described by Gordon Wasson in LIFE magazine (1957) is today an endangered species. This article describes how mycologists located the fungus Conocybe siligeneoides in the Sierra Mazateca of Oaxaca (Mexico).
Face-eating zombies, bulletproof criminals, and rampant death of all involved. These seem to be among the most common media stories floated around when discussing...
In a historic election on Tuesday May 7, 2019, Denver, Colorado became the first city in the United States to decriminalize psilocybin mushrooms. The voter approved...
Almost a decade ago, Breaking Convention hosted the UK’s first-ever psychedelic conference at University of Kent (UK). Little did the organizers know, back then,...
When Spaniards first arrived in the Americas, they encountered an array of mood altering substances, from tobacco, to chocolate, peyote, and ololiuqui. They debated...
Internal letter of recommendations
We, the representatives of the Indigenous Peoples of
the Juruá Valley — Apolima-Arara, Ashaninka, Huni Kuin, Jaminawa,
Jaminawa-Arara, Kuntanawa, Nawa, Noke Koi, Nukini,...
Not-for-profit organizations, like MAPS and Usona Institute, are just a few years away from completing FDA trials to medicalize psychedelic therapy. As psychedelic research gets closer to medicalization, for-profit companies, like COMPASS institute and ATAI Life Sciences, have filed patents about psilocybin, MDMA, and DMT. The author describes how for-profit’s patent claims and capitalism are impacting the psychedelic renaissance -- a movement with origins of psychedelic research in the 1960s, the summer of love, and healing for all.
Jon Dennis provides a thorough guide to the Community Practitioner Framework for psilocybin services under the Oregon Psilocybin Services Act. The primer includes a history of the framework, highlights of the framework, and an overview of the Oregon Department of Justice memo.